Pharma & Healthcare
Global ALK Inhibitors Market Research Report 2024
- Aug 28, 24
- ID: 513996
- Pages: 83
- Figures: 84
- Views: 5
ALK inhibitors are a class of targeted cancer therapies designed to treat tumors with alterations in the ALK (anaplastic lymphoma kinase) gene.By specifically blocking the activity of the ALK protein,these inhibitors help to impede cancer cell growth and proliferation,which are primarily used in treating non-small cell lung cancer (NSCLC) that harbors ALK mutations or rearrangements.
The global ALK Inhibitors market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for ALK Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for ALK Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of ALK Inhibitors include Pfizer, Novartis, Roche, Takeda Pharmaceuticals, Betta Pharmaceuticals, Qilu Pharmaceutical, Wanbang Biopharmaceuticals, Jiangsu Aosaikang Pharmaceutical, Natco Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for ALK Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ALK Inhibitors.
The ALK Inhibitors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global ALK Inhibitors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the ALK Inhibitors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Pfizer
Novartis
Roche
Takeda Pharmaceuticals
Betta Pharmaceuticals
Qilu Pharmaceutical
Wanbang Biopharmaceuticals
Jiangsu Aosaikang Pharmaceutical
Natco Pharma
Segment by Type
Crizotinib
Ceritinib
Ensartinib
Alectinib
Brigatinib
Lorlatinib
Iruplinalkib
Other
Segment by Application
Hospital and Clinic
Retail Pharmacies
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of ALK Inhibitors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of ALK Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global ALK Inhibitors market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for ALK Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for ALK Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of ALK Inhibitors include Pfizer, Novartis, Roche, Takeda Pharmaceuticals, Betta Pharmaceuticals, Qilu Pharmaceutical, Wanbang Biopharmaceuticals, Jiangsu Aosaikang Pharmaceutical, Natco Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for ALK Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ALK Inhibitors.
The ALK Inhibitors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global ALK Inhibitors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the ALK Inhibitors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Pfizer
Novartis
Roche
Takeda Pharmaceuticals
Betta Pharmaceuticals
Qilu Pharmaceutical
Wanbang Biopharmaceuticals
Jiangsu Aosaikang Pharmaceutical
Natco Pharma
Segment by Type
Crizotinib
Ceritinib
Ensartinib
Alectinib
Brigatinib
Lorlatinib
Iruplinalkib
Other
Segment by Application
Hospital and Clinic
Retail Pharmacies
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of ALK Inhibitors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of ALK Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 ALK Inhibitors Market Overview
1.1 Product Definition
1.2 ALK Inhibitors by Type
1.2.1 Global ALK Inhibitors Market Value Comparison by Type (2024-2030)
1.2.2 Crizotinib
1.2.3 Ceritinib
1.2.4 Ensartinib
1.2.5 Alectinib
1.2.6 Brigatinib
1.2.7 Lorlatinib
1.2.8 Iruplinalkib
1.2.9 Other
1.3 ALK Inhibitors by Application
1.3.1 Global ALK Inhibitors Market Value by Application (2024-2030)
1.3.2 Hospital and Clinic
1.3.3 Retail Pharmacies
1.3.4 Other
1.4 Global ALK Inhibitors Market Size Estimates and Forecasts
1.4.1 Global ALK Inhibitors Revenue 2019-2030
1.4.2 Global ALK Inhibitors Sales 2019-2030
1.4.3 Global ALK Inhibitors Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 ALK Inhibitors Market Competition by Manufacturers
2.1 Global ALK Inhibitors Sales Market Share by Manufacturers (2019-2024)
2.2 Global ALK Inhibitors Revenue Market Share by Manufacturers (2019-2024)
2.3 Global ALK Inhibitors Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of ALK Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of ALK Inhibitors, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of ALK Inhibitors, Product Type & Application
2.7 Global Key Manufacturers of ALK Inhibitors, Date of Enter into This Industry
2.8 Global ALK Inhibitors Market Competitive Situation and Trends
2.8.1 Global ALK Inhibitors Market Concentration Rate
2.8.2 The Global 5 and 10 Largest ALK Inhibitors Players Market Share by Revenue
2.8.3 Global ALK Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global ALK Inhibitors Market Scenario by Region
3.1 Global ALK Inhibitors Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global ALK Inhibitors Sales by Region: 2019-2030
3.2.1 Global ALK Inhibitors Sales by Region: 2019-2024
3.2.2 Global ALK Inhibitors Sales by Region: 2025-2030
3.3 Global ALK Inhibitors Revenue by Region: 2019-2030
3.3.1 Global ALK Inhibitors Revenue by Region: 2019-2024
3.3.2 Global ALK Inhibitors Revenue by Region: 2025-2030
3.4 North America ALK Inhibitors Market Facts & Figures by Country
3.4.1 North America ALK Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America ALK Inhibitors Sales by Country (2019-2030)
3.4.3 North America ALK Inhibitors Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe ALK Inhibitors Market Facts & Figures by Country
3.5.1 Europe ALK Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe ALK Inhibitors Sales by Country (2019-2030)
3.5.3 Europe ALK Inhibitors Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific ALK Inhibitors Market Facts & Figures by Region
3.6.1 Asia Pacific ALK Inhibitors Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific ALK Inhibitors Sales by Region (2019-2030)
3.6.3 Asia Pacific ALK Inhibitors Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America ALK Inhibitors Market Facts & Figures by Country
3.7.1 Latin America ALK Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America ALK Inhibitors Sales by Country (2019-2030)
3.7.3 Latin America ALK Inhibitors Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa ALK Inhibitors Market Facts & Figures by Country
3.8.1 Middle East and Africa ALK Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa ALK Inhibitors Sales by Country (2019-2030)
3.8.3 Middle East and Africa ALK Inhibitors Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global ALK Inhibitors Sales by Type (2019-2030)
4.1.1 Global ALK Inhibitors Sales by Type (2019-2024)
4.1.2 Global ALK Inhibitors Sales by Type (2025-2030)
4.1.3 Global ALK Inhibitors Sales Market Share by Type (2019-2030)
4.2 Global ALK Inhibitors Revenue by Type (2019-2030)
4.2.1 Global ALK Inhibitors Revenue by Type (2019-2024)
4.2.2 Global ALK Inhibitors Revenue by Type (2025-2030)
4.2.3 Global ALK Inhibitors Revenue Market Share by Type (2019-2030)
4.3 Global ALK Inhibitors Price by Type (2019-2030)
5 Segment by Application
5.1 Global ALK Inhibitors Sales by Application (2019-2030)
5.1.1 Global ALK Inhibitors Sales by Application (2019-2024)
5.1.2 Global ALK Inhibitors Sales by Application (2025-2030)
5.1.3 Global ALK Inhibitors Sales Market Share by Application (2019-2030)
5.2 Global ALK Inhibitors Revenue by Application (2019-2030)
5.2.1 Global ALK Inhibitors Revenue by Application (2019-2024)
5.2.2 Global ALK Inhibitors Revenue by Application (2025-2030)
5.2.3 Global ALK Inhibitors Revenue Market Share by Application (2019-2030)
5.3 Global ALK Inhibitors Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer ALK Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer ALK Inhibitors Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Company Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis ALK Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novartis ALK Inhibitors Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Roche
6.3.1 Roche Company Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche ALK Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Roche ALK Inhibitors Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 Takeda Pharmaceuticals
6.4.1 Takeda Pharmaceuticals Company Information
6.4.2 Takeda Pharmaceuticals Description and Business Overview
6.4.3 Takeda Pharmaceuticals ALK Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Takeda Pharmaceuticals ALK Inhibitors Product Portfolio
6.4.5 Takeda Pharmaceuticals Recent Developments/Updates
6.5 Betta Pharmaceuticals
6.5.1 Betta Pharmaceuticals Company Information
6.5.2 Betta Pharmaceuticals Description and Business Overview
6.5.3 Betta Pharmaceuticals ALK Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Betta Pharmaceuticals ALK Inhibitors Product Portfolio
6.5.5 Betta Pharmaceuticals Recent Developments/Updates
6.6 Qilu Pharmaceutical
6.6.1 Qilu Pharmaceutical Company Information
6.6.2 Qilu Pharmaceutical Description and Business Overview
6.6.3 Qilu Pharmaceutical ALK Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Qilu Pharmaceutical ALK Inhibitors Product Portfolio
6.6.5 Qilu Pharmaceutical Recent Developments/Updates
6.7 Wanbang Biopharmaceuticals
6.7.1 Wanbang Biopharmaceuticals Company Information
6.7.2 Wanbang Biopharmaceuticals Description and Business Overview
6.7.3 Wanbang Biopharmaceuticals ALK Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Wanbang Biopharmaceuticals ALK Inhibitors Product Portfolio
6.7.5 Wanbang Biopharmaceuticals Recent Developments/Updates
6.8 Jiangsu Aosaikang Pharmaceutical
6.8.1 Jiangsu Aosaikang Pharmaceutical Company Information
6.8.2 Jiangsu Aosaikang Pharmaceutical Description and Business Overview
6.8.3 Jiangsu Aosaikang Pharmaceutical ALK Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Jiangsu Aosaikang Pharmaceutical ALK Inhibitors Product Portfolio
6.8.5 Jiangsu Aosaikang Pharmaceutical Recent Developments/Updates
6.9 Natco Pharma
6.9.1 Natco Pharma Company Information
6.9.2 Natco Pharma Description and Business Overview
6.9.3 Natco Pharma ALK Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Natco Pharma ALK Inhibitors Product Portfolio
6.9.5 Natco Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 ALK Inhibitors Industry Chain Analysis
7.2 ALK Inhibitors Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 ALK Inhibitors Production Mode & Process
7.4 ALK Inhibitors Sales and Marketing
7.4.1 ALK Inhibitors Sales Channels
7.4.2 ALK Inhibitors Distributors
7.5 ALK Inhibitors Customers
8 ALK Inhibitors Market Dynamics
8.1 ALK Inhibitors Industry Trends
8.2 ALK Inhibitors Market Drivers
8.3 ALK Inhibitors Market Challenges
8.4 ALK Inhibitors Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 ALK Inhibitors by Type
1.2.1 Global ALK Inhibitors Market Value Comparison by Type (2024-2030)
1.2.2 Crizotinib
1.2.3 Ceritinib
1.2.4 Ensartinib
1.2.5 Alectinib
1.2.6 Brigatinib
1.2.7 Lorlatinib
1.2.8 Iruplinalkib
1.2.9 Other
1.3 ALK Inhibitors by Application
1.3.1 Global ALK Inhibitors Market Value by Application (2024-2030)
1.3.2 Hospital and Clinic
1.3.3 Retail Pharmacies
1.3.4 Other
1.4 Global ALK Inhibitors Market Size Estimates and Forecasts
1.4.1 Global ALK Inhibitors Revenue 2019-2030
1.4.2 Global ALK Inhibitors Sales 2019-2030
1.4.3 Global ALK Inhibitors Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 ALK Inhibitors Market Competition by Manufacturers
2.1 Global ALK Inhibitors Sales Market Share by Manufacturers (2019-2024)
2.2 Global ALK Inhibitors Revenue Market Share by Manufacturers (2019-2024)
2.3 Global ALK Inhibitors Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of ALK Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of ALK Inhibitors, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of ALK Inhibitors, Product Type & Application
2.7 Global Key Manufacturers of ALK Inhibitors, Date of Enter into This Industry
2.8 Global ALK Inhibitors Market Competitive Situation and Trends
2.8.1 Global ALK Inhibitors Market Concentration Rate
2.8.2 The Global 5 and 10 Largest ALK Inhibitors Players Market Share by Revenue
2.8.3 Global ALK Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global ALK Inhibitors Market Scenario by Region
3.1 Global ALK Inhibitors Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global ALK Inhibitors Sales by Region: 2019-2030
3.2.1 Global ALK Inhibitors Sales by Region: 2019-2024
3.2.2 Global ALK Inhibitors Sales by Region: 2025-2030
3.3 Global ALK Inhibitors Revenue by Region: 2019-2030
3.3.1 Global ALK Inhibitors Revenue by Region: 2019-2024
3.3.2 Global ALK Inhibitors Revenue by Region: 2025-2030
3.4 North America ALK Inhibitors Market Facts & Figures by Country
3.4.1 North America ALK Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America ALK Inhibitors Sales by Country (2019-2030)
3.4.3 North America ALK Inhibitors Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe ALK Inhibitors Market Facts & Figures by Country
3.5.1 Europe ALK Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe ALK Inhibitors Sales by Country (2019-2030)
3.5.3 Europe ALK Inhibitors Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific ALK Inhibitors Market Facts & Figures by Region
3.6.1 Asia Pacific ALK Inhibitors Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific ALK Inhibitors Sales by Region (2019-2030)
3.6.3 Asia Pacific ALK Inhibitors Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America ALK Inhibitors Market Facts & Figures by Country
3.7.1 Latin America ALK Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America ALK Inhibitors Sales by Country (2019-2030)
3.7.3 Latin America ALK Inhibitors Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa ALK Inhibitors Market Facts & Figures by Country
3.8.1 Middle East and Africa ALK Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa ALK Inhibitors Sales by Country (2019-2030)
3.8.3 Middle East and Africa ALK Inhibitors Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global ALK Inhibitors Sales by Type (2019-2030)
4.1.1 Global ALK Inhibitors Sales by Type (2019-2024)
4.1.2 Global ALK Inhibitors Sales by Type (2025-2030)
4.1.3 Global ALK Inhibitors Sales Market Share by Type (2019-2030)
4.2 Global ALK Inhibitors Revenue by Type (2019-2030)
4.2.1 Global ALK Inhibitors Revenue by Type (2019-2024)
4.2.2 Global ALK Inhibitors Revenue by Type (2025-2030)
4.2.3 Global ALK Inhibitors Revenue Market Share by Type (2019-2030)
4.3 Global ALK Inhibitors Price by Type (2019-2030)
5 Segment by Application
5.1 Global ALK Inhibitors Sales by Application (2019-2030)
5.1.1 Global ALK Inhibitors Sales by Application (2019-2024)
5.1.2 Global ALK Inhibitors Sales by Application (2025-2030)
5.1.3 Global ALK Inhibitors Sales Market Share by Application (2019-2030)
5.2 Global ALK Inhibitors Revenue by Application (2019-2030)
5.2.1 Global ALK Inhibitors Revenue by Application (2019-2024)
5.2.2 Global ALK Inhibitors Revenue by Application (2025-2030)
5.2.3 Global ALK Inhibitors Revenue Market Share by Application (2019-2030)
5.3 Global ALK Inhibitors Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer ALK Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer ALK Inhibitors Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Company Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis ALK Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novartis ALK Inhibitors Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Roche
6.3.1 Roche Company Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche ALK Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Roche ALK Inhibitors Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 Takeda Pharmaceuticals
6.4.1 Takeda Pharmaceuticals Company Information
6.4.2 Takeda Pharmaceuticals Description and Business Overview
6.4.3 Takeda Pharmaceuticals ALK Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Takeda Pharmaceuticals ALK Inhibitors Product Portfolio
6.4.5 Takeda Pharmaceuticals Recent Developments/Updates
6.5 Betta Pharmaceuticals
6.5.1 Betta Pharmaceuticals Company Information
6.5.2 Betta Pharmaceuticals Description and Business Overview
6.5.3 Betta Pharmaceuticals ALK Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Betta Pharmaceuticals ALK Inhibitors Product Portfolio
6.5.5 Betta Pharmaceuticals Recent Developments/Updates
6.6 Qilu Pharmaceutical
6.6.1 Qilu Pharmaceutical Company Information
6.6.2 Qilu Pharmaceutical Description and Business Overview
6.6.3 Qilu Pharmaceutical ALK Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Qilu Pharmaceutical ALK Inhibitors Product Portfolio
6.6.5 Qilu Pharmaceutical Recent Developments/Updates
6.7 Wanbang Biopharmaceuticals
6.7.1 Wanbang Biopharmaceuticals Company Information
6.7.2 Wanbang Biopharmaceuticals Description and Business Overview
6.7.3 Wanbang Biopharmaceuticals ALK Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Wanbang Biopharmaceuticals ALK Inhibitors Product Portfolio
6.7.5 Wanbang Biopharmaceuticals Recent Developments/Updates
6.8 Jiangsu Aosaikang Pharmaceutical
6.8.1 Jiangsu Aosaikang Pharmaceutical Company Information
6.8.2 Jiangsu Aosaikang Pharmaceutical Description and Business Overview
6.8.3 Jiangsu Aosaikang Pharmaceutical ALK Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Jiangsu Aosaikang Pharmaceutical ALK Inhibitors Product Portfolio
6.8.5 Jiangsu Aosaikang Pharmaceutical Recent Developments/Updates
6.9 Natco Pharma
6.9.1 Natco Pharma Company Information
6.9.2 Natco Pharma Description and Business Overview
6.9.3 Natco Pharma ALK Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Natco Pharma ALK Inhibitors Product Portfolio
6.9.5 Natco Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 ALK Inhibitors Industry Chain Analysis
7.2 ALK Inhibitors Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 ALK Inhibitors Production Mode & Process
7.4 ALK Inhibitors Sales and Marketing
7.4.1 ALK Inhibitors Sales Channels
7.4.2 ALK Inhibitors Distributors
7.5 ALK Inhibitors Customers
8 ALK Inhibitors Market Dynamics
8.1 ALK Inhibitors Industry Trends
8.2 ALK Inhibitors Market Drivers
8.3 ALK Inhibitors Market Challenges
8.4 ALK Inhibitors Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global ALK Inhibitors Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global ALK Inhibitors Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global ALK Inhibitors Market Competitive Situation by Manufacturers in 2023
Table 4. Global ALK Inhibitors Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global ALK Inhibitors Sales Market Share by Manufacturers (2019-2024)
Table 6. Global ALK Inhibitors Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global ALK Inhibitors Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market ALK Inhibitors Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of ALK Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of ALK Inhibitors, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of ALK Inhibitors, Product Type & Application
Table 12. Global Key Manufacturers of ALK Inhibitors, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global ALK Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ALK Inhibitors as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global ALK Inhibitors Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global ALK Inhibitors Sales by Region (2019-2024) & (K Units)
Table 18. Global ALK Inhibitors Sales Market Share by Region (2019-2024)
Table 19. Global ALK Inhibitors Sales by Region (2025-2030) & (K Units)
Table 20. Global ALK Inhibitors Sales Market Share by Region (2025-2030)
Table 21. Global ALK Inhibitors Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global ALK Inhibitors Revenue Market Share by Region (2019-2024)
Table 23. Global ALK Inhibitors Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global ALK Inhibitors Revenue Market Share by Region (2025-2030)
Table 25. North America ALK Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America ALK Inhibitors Sales by Country (2019-2024) & (K Units)
Table 27. North America ALK Inhibitors Sales by Country (2025-2030) & (K Units)
Table 28. North America ALK Inhibitors Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America ALK Inhibitors Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe ALK Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe ALK Inhibitors Sales by Country (2019-2024) & (K Units)
Table 32. Europe ALK Inhibitors Sales by Country (2025-2030) & (K Units)
Table 33. Europe ALK Inhibitors Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe ALK Inhibitors Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific ALK Inhibitors Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific ALK Inhibitors Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific ALK Inhibitors Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific ALK Inhibitors Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific ALK Inhibitors Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America ALK Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America ALK Inhibitors Sales by Country (2019-2024) & (K Units)
Table 42. Latin America ALK Inhibitors Sales by Country (2025-2030) & (K Units)
Table 43. Latin America ALK Inhibitors Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America ALK Inhibitors Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa ALK Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa ALK Inhibitors Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa ALK Inhibitors Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa ALK Inhibitors Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa ALK Inhibitors Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global ALK Inhibitors Sales (K Units) by Type (2019-2024)
Table 51. Global ALK Inhibitors Sales (K Units) by Type (2025-2030)
Table 52. Global ALK Inhibitors Sales Market Share by Type (2019-2024)
Table 53. Global ALK Inhibitors Sales Market Share by Type (2025-2030)
Table 54. Global ALK Inhibitors Revenue (US$ Million) by Type (2019-2024)
Table 55. Global ALK Inhibitors Revenue (US$ Million) by Type (2025-2030)
Table 56. Global ALK Inhibitors Revenue Market Share by Type (2019-2024)
Table 57. Global ALK Inhibitors Revenue Market Share by Type (2025-2030)
Table 58. Global ALK Inhibitors Price (US$/Unit) by Type (2019-2024)
Table 59. Global ALK Inhibitors Price (US$/Unit) by Type (2025-2030)
Table 60. Global ALK Inhibitors Sales (K Units) by Application (2019-2024)
Table 61. Global ALK Inhibitors Sales (K Units) by Application (2025-2030)
Table 62. Global ALK Inhibitors Sales Market Share by Application (2019-2024)
Table 63. Global ALK Inhibitors Sales Market Share by Application (2025-2030)
Table 64. Global ALK Inhibitors Revenue (US$ Million) by Application (2019-2024)
Table 65. Global ALK Inhibitors Revenue (US$ Million) by Application (2025-2030)
Table 66. Global ALK Inhibitors Revenue Market Share by Application (2019-2024)
Table 67. Global ALK Inhibitors Revenue Market Share by Application (2025-2030)
Table 68. Global ALK Inhibitors Price (US$/Unit) by Application (2019-2024)
Table 69. Global ALK Inhibitors Price (US$/Unit) by Application (2025-2030)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer ALK Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Pfizer ALK Inhibitors Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Novartis Company Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis ALK Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Novartis ALK Inhibitors Product
Table 79. Novartis Recent Developments/Updates
Table 80. Roche Company Information
Table 81. Roche Description and Business Overview
Table 82. Roche ALK Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Roche ALK Inhibitors Product
Table 84. Roche Recent Developments/Updates
Table 85. Takeda Pharmaceuticals Company Information
Table 86. Takeda Pharmaceuticals Description and Business Overview
Table 87. Takeda Pharmaceuticals ALK Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Takeda Pharmaceuticals ALK Inhibitors Product
Table 89. Takeda Pharmaceuticals Recent Developments/Updates
Table 90. Betta Pharmaceuticals Company Information
Table 91. Betta Pharmaceuticals Description and Business Overview
Table 92. Betta Pharmaceuticals ALK Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Betta Pharmaceuticals ALK Inhibitors Product
Table 94. Betta Pharmaceuticals Recent Developments/Updates
Table 95. Qilu Pharmaceutical Company Information
Table 96. Qilu Pharmaceutical Description and Business Overview
Table 97. Qilu Pharmaceutical ALK Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Qilu Pharmaceutical ALK Inhibitors Product
Table 99. Qilu Pharmaceutical Recent Developments/Updates
Table 100. Wanbang Biopharmaceuticals Company Information
Table 101. Wanbang Biopharmaceuticals Description and Business Overview
Table 102. Wanbang Biopharmaceuticals ALK Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Wanbang Biopharmaceuticals ALK Inhibitors Product
Table 104. Wanbang Biopharmaceuticals Recent Developments/Updates
Table 105. Jiangsu Aosaikang Pharmaceutical Company Information
Table 106. Jiangsu Aosaikang Pharmaceutical Description and Business Overview
Table 107. Jiangsu Aosaikang Pharmaceutical ALK Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Jiangsu Aosaikang Pharmaceutical ALK Inhibitors Product
Table 109. Jiangsu Aosaikang Pharmaceutical Recent Developments/Updates
Table 110. Natco Pharma Company Information
Table 111. Natco Pharma Description and Business Overview
Table 112. Natco Pharma ALK Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Natco Pharma ALK Inhibitors Product
Table 114. Natco Pharma Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. ALK Inhibitors Distributors List
Table 118. ALK Inhibitors Customers List
Table 119. ALK Inhibitors Market Trends
Table 120. ALK Inhibitors Market Drivers
Table 121. ALK Inhibitors Market Challenges
Table 122. ALK Inhibitors Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of ALK Inhibitors
Figure 2. Global ALK Inhibitors Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global ALK Inhibitors Market Share by Type: 2023 & 2030
Figure 4. Crizotinib Product Picture
Figure 5. Ceritinib Product Picture
Figure 6. Ensartinib Product Picture
Figure 7. Alectinib Product Picture
Figure 8. Brigatinib Product Picture
Figure 9. Lorlatinib Product Picture
Figure 10. Iruplinalkib Product Picture
Figure 11. Other Product Picture
Figure 12. Global ALK Inhibitors Market Value by Application (2024-2030) & (US$ Million)
Figure 13. Global ALK Inhibitors Market Share by Application: 2023 & 2030
Figure 14. Hospital and Clinic
Figure 15. Retail Pharmacies
Figure 16. Other
Figure 17. Global ALK Inhibitors Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global ALK Inhibitors Market Size (2019-2030) & (US$ Million)
Figure 19. Global ALK Inhibitors Sales (2019-2030) & (K Units)
Figure 20. Global ALK Inhibitors Average Price (US$/Unit) & (2019-2030)
Figure 21. ALK Inhibitors Report Years Considered
Figure 22. ALK Inhibitors Sales Share by Manufacturers in 2023
Figure 23. Global ALK Inhibitors Revenue Share by Manufacturers in 2023
Figure 24. Global 5 and 10 Largest ALK Inhibitors Players: Market Share by Revenue in ALK Inhibitors in 2023
Figure 25. ALK Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 26. Global ALK Inhibitors Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 27. North America ALK Inhibitors Sales Market Share by Country (2019-2030)
Figure 28. North America ALK Inhibitors Revenue Market Share by Country (2019-2030)
Figure 29. United States ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Canada ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Europe ALK Inhibitors Sales Market Share by Country (2019-2030)
Figure 32. Europe ALK Inhibitors Revenue Market Share by Country (2019-2030)
Figure 33. Germany ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. France ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. U.K. ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Italy ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Russia ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Asia Pacific ALK Inhibitors Sales Market Share by Region (2019-2030)
Figure 39. Asia Pacific ALK Inhibitors Revenue Market Share by Region (2019-2030)
Figure 40. China ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Japan ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. South Korea ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. India ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Australia ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. China Taiwan ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Southeast Asia ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Latin America ALK Inhibitors Sales Market Share by Country (2019-2030)
Figure 48. Mexico ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Colombia ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Middle East and Africa ALK Inhibitors Sales Market Share by Country (2019-2030)
Figure 53. Middle East and Africa ALK Inhibitors Revenue Market Share by Country (2019-2030)
Figure 54. Turkey ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. UAE ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Global Sales Market Share of ALK Inhibitors by Type (2019-2030)
Figure 58. Global Revenue Market Share of ALK Inhibitors by Type (2019-2030)
Figure 59. Global ALK Inhibitors Price (US$/Unit) by Type (2019-2030)
Figure 60. Global Sales Market Share of ALK Inhibitors by Application (2019-2030)
Figure 61. Global Revenue Market Share of ALK Inhibitors by Application (2019-2030)
Figure 62. Global ALK Inhibitors Price (US$/Unit) by Application (2019-2030)
Figure 63. ALK Inhibitors Value Chain
Figure 64. ALK Inhibitors Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Table 1. Global ALK Inhibitors Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global ALK Inhibitors Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global ALK Inhibitors Market Competitive Situation by Manufacturers in 2023
Table 4. Global ALK Inhibitors Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global ALK Inhibitors Sales Market Share by Manufacturers (2019-2024)
Table 6. Global ALK Inhibitors Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global ALK Inhibitors Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market ALK Inhibitors Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of ALK Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of ALK Inhibitors, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of ALK Inhibitors, Product Type & Application
Table 12. Global Key Manufacturers of ALK Inhibitors, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global ALK Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ALK Inhibitors as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global ALK Inhibitors Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global ALK Inhibitors Sales by Region (2019-2024) & (K Units)
Table 18. Global ALK Inhibitors Sales Market Share by Region (2019-2024)
Table 19. Global ALK Inhibitors Sales by Region (2025-2030) & (K Units)
Table 20. Global ALK Inhibitors Sales Market Share by Region (2025-2030)
Table 21. Global ALK Inhibitors Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global ALK Inhibitors Revenue Market Share by Region (2019-2024)
Table 23. Global ALK Inhibitors Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global ALK Inhibitors Revenue Market Share by Region (2025-2030)
Table 25. North America ALK Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America ALK Inhibitors Sales by Country (2019-2024) & (K Units)
Table 27. North America ALK Inhibitors Sales by Country (2025-2030) & (K Units)
Table 28. North America ALK Inhibitors Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America ALK Inhibitors Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe ALK Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe ALK Inhibitors Sales by Country (2019-2024) & (K Units)
Table 32. Europe ALK Inhibitors Sales by Country (2025-2030) & (K Units)
Table 33. Europe ALK Inhibitors Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe ALK Inhibitors Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific ALK Inhibitors Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific ALK Inhibitors Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific ALK Inhibitors Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific ALK Inhibitors Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific ALK Inhibitors Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America ALK Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America ALK Inhibitors Sales by Country (2019-2024) & (K Units)
Table 42. Latin America ALK Inhibitors Sales by Country (2025-2030) & (K Units)
Table 43. Latin America ALK Inhibitors Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America ALK Inhibitors Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa ALK Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa ALK Inhibitors Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa ALK Inhibitors Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa ALK Inhibitors Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa ALK Inhibitors Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global ALK Inhibitors Sales (K Units) by Type (2019-2024)
Table 51. Global ALK Inhibitors Sales (K Units) by Type (2025-2030)
Table 52. Global ALK Inhibitors Sales Market Share by Type (2019-2024)
Table 53. Global ALK Inhibitors Sales Market Share by Type (2025-2030)
Table 54. Global ALK Inhibitors Revenue (US$ Million) by Type (2019-2024)
Table 55. Global ALK Inhibitors Revenue (US$ Million) by Type (2025-2030)
Table 56. Global ALK Inhibitors Revenue Market Share by Type (2019-2024)
Table 57. Global ALK Inhibitors Revenue Market Share by Type (2025-2030)
Table 58. Global ALK Inhibitors Price (US$/Unit) by Type (2019-2024)
Table 59. Global ALK Inhibitors Price (US$/Unit) by Type (2025-2030)
Table 60. Global ALK Inhibitors Sales (K Units) by Application (2019-2024)
Table 61. Global ALK Inhibitors Sales (K Units) by Application (2025-2030)
Table 62. Global ALK Inhibitors Sales Market Share by Application (2019-2024)
Table 63. Global ALK Inhibitors Sales Market Share by Application (2025-2030)
Table 64. Global ALK Inhibitors Revenue (US$ Million) by Application (2019-2024)
Table 65. Global ALK Inhibitors Revenue (US$ Million) by Application (2025-2030)
Table 66. Global ALK Inhibitors Revenue Market Share by Application (2019-2024)
Table 67. Global ALK Inhibitors Revenue Market Share by Application (2025-2030)
Table 68. Global ALK Inhibitors Price (US$/Unit) by Application (2019-2024)
Table 69. Global ALK Inhibitors Price (US$/Unit) by Application (2025-2030)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer ALK Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Pfizer ALK Inhibitors Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Novartis Company Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis ALK Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Novartis ALK Inhibitors Product
Table 79. Novartis Recent Developments/Updates
Table 80. Roche Company Information
Table 81. Roche Description and Business Overview
Table 82. Roche ALK Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Roche ALK Inhibitors Product
Table 84. Roche Recent Developments/Updates
Table 85. Takeda Pharmaceuticals Company Information
Table 86. Takeda Pharmaceuticals Description and Business Overview
Table 87. Takeda Pharmaceuticals ALK Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Takeda Pharmaceuticals ALK Inhibitors Product
Table 89. Takeda Pharmaceuticals Recent Developments/Updates
Table 90. Betta Pharmaceuticals Company Information
Table 91. Betta Pharmaceuticals Description and Business Overview
Table 92. Betta Pharmaceuticals ALK Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Betta Pharmaceuticals ALK Inhibitors Product
Table 94. Betta Pharmaceuticals Recent Developments/Updates
Table 95. Qilu Pharmaceutical Company Information
Table 96. Qilu Pharmaceutical Description and Business Overview
Table 97. Qilu Pharmaceutical ALK Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Qilu Pharmaceutical ALK Inhibitors Product
Table 99. Qilu Pharmaceutical Recent Developments/Updates
Table 100. Wanbang Biopharmaceuticals Company Information
Table 101. Wanbang Biopharmaceuticals Description and Business Overview
Table 102. Wanbang Biopharmaceuticals ALK Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Wanbang Biopharmaceuticals ALK Inhibitors Product
Table 104. Wanbang Biopharmaceuticals Recent Developments/Updates
Table 105. Jiangsu Aosaikang Pharmaceutical Company Information
Table 106. Jiangsu Aosaikang Pharmaceutical Description and Business Overview
Table 107. Jiangsu Aosaikang Pharmaceutical ALK Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Jiangsu Aosaikang Pharmaceutical ALK Inhibitors Product
Table 109. Jiangsu Aosaikang Pharmaceutical Recent Developments/Updates
Table 110. Natco Pharma Company Information
Table 111. Natco Pharma Description and Business Overview
Table 112. Natco Pharma ALK Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Natco Pharma ALK Inhibitors Product
Table 114. Natco Pharma Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. ALK Inhibitors Distributors List
Table 118. ALK Inhibitors Customers List
Table 119. ALK Inhibitors Market Trends
Table 120. ALK Inhibitors Market Drivers
Table 121. ALK Inhibitors Market Challenges
Table 122. ALK Inhibitors Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of ALK Inhibitors
Figure 2. Global ALK Inhibitors Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global ALK Inhibitors Market Share by Type: 2023 & 2030
Figure 4. Crizotinib Product Picture
Figure 5. Ceritinib Product Picture
Figure 6. Ensartinib Product Picture
Figure 7. Alectinib Product Picture
Figure 8. Brigatinib Product Picture
Figure 9. Lorlatinib Product Picture
Figure 10. Iruplinalkib Product Picture
Figure 11. Other Product Picture
Figure 12. Global ALK Inhibitors Market Value by Application (2024-2030) & (US$ Million)
Figure 13. Global ALK Inhibitors Market Share by Application: 2023 & 2030
Figure 14. Hospital and Clinic
Figure 15. Retail Pharmacies
Figure 16. Other
Figure 17. Global ALK Inhibitors Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global ALK Inhibitors Market Size (2019-2030) & (US$ Million)
Figure 19. Global ALK Inhibitors Sales (2019-2030) & (K Units)
Figure 20. Global ALK Inhibitors Average Price (US$/Unit) & (2019-2030)
Figure 21. ALK Inhibitors Report Years Considered
Figure 22. ALK Inhibitors Sales Share by Manufacturers in 2023
Figure 23. Global ALK Inhibitors Revenue Share by Manufacturers in 2023
Figure 24. Global 5 and 10 Largest ALK Inhibitors Players: Market Share by Revenue in ALK Inhibitors in 2023
Figure 25. ALK Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 26. Global ALK Inhibitors Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 27. North America ALK Inhibitors Sales Market Share by Country (2019-2030)
Figure 28. North America ALK Inhibitors Revenue Market Share by Country (2019-2030)
Figure 29. United States ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Canada ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Europe ALK Inhibitors Sales Market Share by Country (2019-2030)
Figure 32. Europe ALK Inhibitors Revenue Market Share by Country (2019-2030)
Figure 33. Germany ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. France ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. U.K. ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Italy ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Russia ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Asia Pacific ALK Inhibitors Sales Market Share by Region (2019-2030)
Figure 39. Asia Pacific ALK Inhibitors Revenue Market Share by Region (2019-2030)
Figure 40. China ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Japan ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. South Korea ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. India ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Australia ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. China Taiwan ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Southeast Asia ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Latin America ALK Inhibitors Sales Market Share by Country (2019-2030)
Figure 48. Mexico ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Colombia ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Middle East and Africa ALK Inhibitors Sales Market Share by Country (2019-2030)
Figure 53. Middle East and Africa ALK Inhibitors Revenue Market Share by Country (2019-2030)
Figure 54. Turkey ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. UAE ALK Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Global Sales Market Share of ALK Inhibitors by Type (2019-2030)
Figure 58. Global Revenue Market Share of ALK Inhibitors by Type (2019-2030)
Figure 59. Global ALK Inhibitors Price (US$/Unit) by Type (2019-2030)
Figure 60. Global Sales Market Share of ALK Inhibitors by Application (2019-2030)
Figure 61. Global Revenue Market Share of ALK Inhibitors by Application (2019-2030)
Figure 62. Global ALK Inhibitors Price (US$/Unit) by Application (2019-2030)
Figure 63. ALK Inhibitors Value Chain
Figure 64. ALK Inhibitors Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Camelina Seeds - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 11, 24
Bentgrass Seeds - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 11, 24
Barley Seeds - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 11, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232